40 Recruiting Alzheimer's Disease Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Alzheimer's Disease
Related Conditions
Top Recruiting Alzheimer's Disease Studies
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia
📍 University of Calgary — Calgary, Alberta
View Study & Checklist ➔A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology
📍 Eisai Site #3 — Clermont, Florida
View Study & Checklist ➔A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
📍 Banner Sun Health Research — Phoenix, Arizona
View Study & Checklist ➔DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
📍 University of Alabama in Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
📍 Parkway Medical Center — Birmingham, Alabama
View Study & Checklist ➔A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
📍 MD First Research - Chandler — Chandler, Arizona
View Study & Checklist ➔Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
📍 GSK Investigational Site — San Diego, California
View Study & Checklist ➔A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
📍 University of California - San Diego — La Jolla, California
View Study & Checklist ➔Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
📍 ATP Clinical Research — Costa Mesa, California
View Study & Checklist ➔A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
📍 Local Institution - 0001 — Anaheim, California
View Study & Checklist ➔A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects
📍 T3D Therapeutics, Inc. — Durham, North Carolina
View Study & Checklist ➔Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
📍 National Institute of Aging, Clinical Research Unit — Baltimore, Maryland
View Study & Checklist ➔Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
📍 Banner Alzheimer's Institute — Phoenix, Arizona
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
📍 Fullerton Neurology and Headache Center — Fullerton, California
View Study & Checklist ➔Wake Forest Alzheimer's Disease Clinical Core
📍 Wake Forest Baptist Health — Winston-Salem, North Carolina
View Study & Checklist ➔A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
📍 Toronto Western Hospital — Toronto, Ontario
View Study & Checklist ➔Open-label Extension Study in Participants With Early Alzheimer's Disease
📍 GSK Investigational Site — Maitland, Florida
View Study & Checklist ➔A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
📍 Banner Alzheimers Institute — Phoenix, Arizona
View Study & Checklist ➔A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
📍 Eisai Trial Site #1 — Nutley, New Jersey
View Study & Checklist ➔A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
📍 Chandler Clinical Trials, LLC — Chandler, Arizona
View Study & Checklist ➔Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
📍 The Ohio State University — Columbus, Ohio
View Study & Checklist ➔A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
📍 Clinical Trial Site — Montreal,
View Study & Checklist ➔A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
📍 Irvine Center for Clinical Research /ID# 277752 — Irvine, California
View Study & Checklist ➔Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music
📍 Northwestern University Feinberg School of Medicine — Chicago, Illinois
View Study & Checklist ➔Pulsed Electromagnetic Field Treatment With Dementia Patients
📍 University of Miami — Boca Raton, Florida
View Study & Checklist ➔Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
📍 CSMC — Los Angeles, California
View Study & Checklist ➔Retinal Imaging in Neurodegenerative Disease
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
📍 Healthy Brain Clinic — Long Beach, California
View Study & Checklist ➔Dominantly Inherited Alzheimer Network (DIAN)
📍 Mayo Clinic Jacksonville — Jacksonville, Florida
View Study & Checklist ➔Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔